Recent advances in the prevention and treatment of skin cancer using photodynamic therapy

References

• Neville JA, Welch E, Leffell DJ. Management of nonmelanoma skin cancer in 2007. Nat. Clin. Pract. Oncol.4(8), 462–469 (2007).
   PubMedGoogle Scholar
• Rogers HW, Weinstock MA, Harris AR et al. Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch. Dermatol.146(3), 283–287 (20110).
   Google Scholar
• Ackroyd R, Kelty C, Brown N, Reed M. The history of photodetection and photodynamic therapy. Photochem. Photobiol.74(5), 656–669 (2001).
   PubMed Web of Science ®Google Scholar
• Daniell MD, Hill JS. A history of photodynamic therapy. Aust. NZ J. Surg.61(5), 340–348 (1991).
   PubMedGoogle Scholar
• Spikes JD. Primary Photoprocesses in Biology and Medicine. Berghausen RV, Jori G, Land EJ, Truscott TH (Eds). Plenum Press, NY, USA, 209–227 (1985).
   Google Scholar
• Fitzpatrick TB, Pathak MA. Historical aspects of methoxsalen and other furocoumarins. J. Invest. Dermatol.32(2), 229–231 (1959).
   PubMed Web of Science ®Google Scholar
• Moan J, Peng Q. An outline of the hundred-year history of PDT. Anticancer Res.23(5A), 3591–3600 (2003).
   PubMed Web of Science ®Google Scholar
• Pinthus JH, Bogaards A, Weersink R, Wilson BC, Trachtenberg J. Photodynamic therapy for urological malignancies: past to current approaches. J. Urol.175(4), 1201–1207 (2006).
   PubMedGoogle Scholar
• Juarranz A, Jaen P, Sanz-Rodriguez F, Cuevas J, Gonzalez S. Photodynamic therapy of cancer. Basic principles and applications. Clin. Transl. Oncol.10(3), 148–154 (2008).
   PubMed Web of Science ®Google Scholar
• Jichlinski P. Photodynamic applications in superficial bladder cancer: facts and hopes! J. Environ. Pathol. Toxicol. Oncol.25(1–2), 441–451 (2006).
   PubMedGoogle Scholar
• Wiedmann MW, Caca K. General principles of photodynamic therapy (PDT) and gastrointestinal applications. Curr. Pharm. Biotechnol.5(4), 397–408 (2004).
   PubMed Web of Science ®Google Scholar
• Barr H, Dix AJ, Kendall C, Stone N. Review article: the potential role for photodynamic therapy in the management of upper gastrointestinal disease. Aliment. Pharmacol. Ther.15(3), 311–321 (2001).
   PubMedGoogle Scholar
• Ost D. Photodynamic therapy in lung cancer. A review. Methods Mol. Med.75, 507–526 (2003).
   PubMedGoogle Scholar
• Sutedja TG, Postmus PE. Photodynamic therapy in lung cancer. A review. J. Photochem. Photobiol. B Biol.36(2), 199–204 (1996).
   PubMedGoogle Scholar
• Photodynamic therapy with verteporfin for age-related macular degeneration. American Academy of Ophthalmology. Ophthalmology107(12), 2314–2317 (2000).
   PubMedGoogle Scholar
• Mittra RA, Singerman LJ. Recent advances in the management of age-related macular degeneration. Optom. Vis. Sci.79(4), 218–224 (2002).
   PubMedGoogle Scholar
• Blume JE, Oseroff AR. Aminolevulinic acid photodynamic therapy for skin cancers. Dermatol. Clin.25(1), 5–14 (2007).
   PubMed Web of Science ®Google Scholar
• Dougherty TJ. A brief history of clinical photodynamic therapy development at Roswell Park Cancer Institute. J. Clin. Laser Med. Surg.14(5), 219–221 (1996).
   PubMedGoogle Scholar
• Zeitouni NC, Oseroff AR, Shieh S. Photodynamic therapy for nonmelanoma skin cancers. Current review and update. Mol. Immunol.39(17–18), 1133–1136 (2003).
   PubMed Web of Science ®Google Scholar
• Kennedy JC, Pottier RH, Pross DC. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J. Photochem. Photobiol. B Biol.6(1–2), 143–148 (1990).
   PubMed Web of Science ®Google Scholar
• Moan J. On the diffusion length of singlet oxygen in cells and tissues. J. Photochem. Photobiol. B Biol.6(3), 343–347 (1990).
   Web of Science ®Google Scholar
• Foote CS. Definition of type I and type II photosensitized oxidation. Photochem. Photobiol.54(5), 659 (1991).
   PubMed Web of Science ®Google Scholar
• Garcia-Zuazaga J, Cooper KD, Baron ED. Photodynamic therapy in dermatology: current concepts in the treatment of skin cancer. Expert Rev. Anticancer Ther.5(5), 791–800 (2005).
   PubMed Web of Science ®Google Scholar
• Kormeili T, Yamauchi PS, Lowe NJ. Topical photodynamic therapy in clinical dermatology. Br. J. Dermatol.150(6), 1061–1069 (2004).
   PubMedGoogle Scholar
• Ceburkov O, Gollnick H. Photodynamic therapy in dermatology. Eur. J. Dermatol.10(7), 568–575 (2000).
   PubMed Web of Science ®Google Scholar
• Cappugi P, Campolmi P, Mavilia L, Prignano F, Rossi R. Topical 5-aminolevulinic acid and photodynamic therapy in dermatology: a minireview. J. Chemother.13(5), 494–502 (2001).
   PubMed Web of Science ®Google Scholar
• Brancaleon L, Moseley H. Laser and non-laser light sources for photodynamic therapy. Lasers Med. Sci.17(3), 173–186 (2002).
   PubMed Web of Science ®Google Scholar
• Palumbo G. Photodynamic therapy and cancer: a brief sightseeing tour. Expert Opin. Drug. Deliv.4(2), 131–148 (2007).
   PubMed Web of Science ®Google Scholar
• Evans J. High-tech bandages lighten the load of light therapy. Nat. Med.15(7), 713 (2009).
   PubMedGoogle Scholar
• Zhu TC, Finlay JC, Hahn SM. Determination of the distribution of light, optical properties, drug concentration, and tissue oxygenation in-vivo in human prostate during motexafin lutetium-mediated photodynamic therapy. J. Photochem. Photobiol. B Biol.79(3), 231–241 (2005).
   PubMed Web of Science ®Google Scholar
• Panjehpour M, Overholt BF, Phan MN, Haydek JM. Optimization of light dosimetry for photodynamic therapy of Barrett’s esophagus: efficacy vs. incidence of stricture after treatment. Gastrointest. Endosc.61(1), 13–18 (2005).
   PubMedGoogle Scholar
• Dragieva G, Scharer L, Dummer R, Kempf W. Photodynamic therapy – a new treatment option for epithelial malignancies of the skin. Onkologie27(4), 407–411 (2004).
   PubMedGoogle Scholar
• Fritsch C, Goerz G, Ruzicka T. Photodynamic therapy in dermatology. Arch. Dermatol.134(2), 207–214 (1998).
   PubMed Web of Science ®Google Scholar
• Moan J, Berg K. Photochemotherapy of cancer: experimental research. Photochem. Photobiol.55(6), 931–948 (1992).
   PubMed Web of Science ®Google Scholar
• Young SW, Woodburn KW, Wright M et al. Lutetium texaphyrin (PCI-0123): a near-infrared, water-soluble photosensitizer. Photochem. Photobiol.63(6), 892–897 (1996).
   PubMed Web of Science ®Google Scholar
• Woodburn KW, Fan Q, Kessel D, Luo Y, Young SW. Photodynamic therapy of B16F10 murine melanoma with lutetium texaphyrin. J. Invest. Dermatol.110(5), 746–751 (1998).
   PubMedGoogle Scholar
• Josefsen LB, Boyle RW. Photodynamic therapy: novel third-generation photosensitizers one step closer? Br. J. Pharmacol.154(1), 1–3 (2008).
   PubMed Web of Science ®Google Scholar
• Babilas P, Karrer S, Sidoroff A, Landthaler M, Szeimies RM. Photodynamic therapy in dermatology – an update. Photodermatol. Photoimmunol. Photomed.21(3), 142–149 (2005).
   PubMedGoogle Scholar
• Morton CA. Methyl aminolevulinate (Metvix) photodynamic therapy – practical pearls. J. Dermatolog. Treat.14(Suppl. 3), 23–26 (2003).
   PubMedGoogle Scholar
• Morton CA, Brown SB, Collins S et al. Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group. Br. J. Dermatol.146(4), 552–567 (2002).
   PubMed Web of Science ®Google Scholar
• Morton CA. Photodynamic therapy for nonmelanoma skin cancer – and more? Arch. Dermatol.140(1), 116–120 (2004).
   PubMedGoogle Scholar
• Morton CA, McKenna KE, Rhodes LE. Guidelines for topical photodynamic therapy: update. Br. J. Dermatol.159(6), 1245–1266 (2008).
   PubMed Web of Science ®Google Scholar
• Basset-Seguin N, Ibbotson SH, Emtestam L et al. Topical methyl aminolaevulinate photodynamic therapy versus cryotherapy for superficial basal cell carcinoma: a 5 year randomized trial. Eur. J. Dermatol.18(5), 547–553 (2008).
   PubMed Web of Science ®Google Scholar
• Lehmann P. Methyl aminolaevulinate-photodynamic therapy: a review of clinical trials in the treatment of actinic keratoses and nonmelanoma skin cancer. Br. J. Dermatol.156(5), 793–801 (2007).
   PubMed Web of Science ®Google Scholar
• Procianoy F, Cruz AA, Baccega A, Ferraz V, Chahud F. Aggravation of eyelid and conjunctival malignancies following photodynamic therapy in DeSanctis–Cacchione syndrome. Ophthal. Plast. Reconstr. Surg.22(6), 498–499 (2006).
   PubMed Web of Science ®Google Scholar
• Holmes MV, Dawe RS, Ferguson J, Ibbotson SH. A randomized, double-blind, placebo-controlled study of the efficacy of tetracaine gel (Ametop) for pain relief during topical photodynamic therapy. Br. J. Dermatol.150(2), 337–340 (2004).
   PubMedGoogle Scholar
• Langan SM, Collins P. Randomized, double-blind, placebo-controlled prospective study of the efficacy of topical anaesthesia with a eutetic mixture of lignocaine 2.5% and prilocaine 2.5% for topical 5-aminolaevulinic acid-photodynamic therapy for extensive scalp actinic keratoses. Br. J. Dermatol.154(1), 146–149 (2006).
   PubMedGoogle Scholar
• Pagliaro J, Elliott T, Bulsara M, King C, Vinciullo C. Cold air analgesia in photodynamic therapy of basal cell carcinomas and Bowen’s disease: an effective addition to treatment: a pilot study. Dermatol. Surg.30(1), 63–66 (2004).
   PubMedGoogle Scholar
• Marks R, Rennie G, Selwood TS. Malignant transformation of solar keratoses to squamous cell carcinoma. Lancet1(8589), 795–797 (1988).
   PubMed Web of Science ®Google Scholar
• Szeimies RM, Karrer S, Sauerwald A, Landthaler M. Photodynamic therapy with topical application of 5-aminolevulinic acid in the treatment of actinic keratoses: an initial clinical study. Dermatology (Basel)192(3), 246–251 (1996).
   PubMed Web of Science ®Google Scholar
• Jeffes EW, McCullough JL, Weinstein GD et al. Photodynamic therapy of actinic keratosis with topical 5-aminolevulinic acid. A pilot dose-ranging study. Arch. Dermatol.133(6), 727–732 (1997).
   PubMed Web of Science ®Google Scholar
• Piacquadio DJ, Chen DM, Farber HF et al. Photodynamic therapy with aminolevulinic acid topical solution and visible blue light in the treatment of multiple actinic keratoses of the face and scalp: investigator-blinded, Phase 3, multicenter trials. Arch. Dermatol.140(1), 41–46 (2004).
   PubMed Web of Science ®Google Scholar
• Kaufmann R, Spelman L, Weightman W et al. Multicentre intraindividual randomized trial of topical methyl aminolaevulinate-photodynamic therapy vs. cryotherapy for multiple actinic keratoses on the extremities. Br. J. Dermatol.158(5), 994–999 (2008).
   PubMed Web of Science ®Google Scholar
• Wiegell SR, Haedersdal M, Eriksen P, Wulf HC. Photodynamic therapy of actinic keratoses with 8% and 16% methyl aminolaevulinate and home-based daylight exposure: a double-blinded randomized clinical trial. Br. J. Dermatol.160(6), 1308–1314 (2009).
   PubMed Web of Science ®Google Scholar
• Hauschild A, Popp G, Stockfleth E et al. Effective photodynamic therapy of actinic keratoses on the head and face with a novel, self-adhesive 5-aminolaevulinic acid patch. Exp. Dermatol.18(2), 116–121 (2009).
   PubMedGoogle Scholar
• Moloney FJ, Collins P. Randomized, double-blind, prospective study to compare topical 5-aminolaevulinic acid methylester with topical 5-aminolaevulinic acid photodynamic therapy for extensive scalp actinic keratosis. Br. J. Dermatol.157(1), 87–91 (2007).
   PubMed Web of Science ®Google Scholar
• Morton C, Campbell S, Gupta G et al. Intraindividual, right–left comparison of topical methyl aminolaevulinate-photodynamic therapy and cryotherapy in subjects with actinic keratoses: a multicentre, randomized controlled study. Br. J. Dermatol.155(5), 1029–1036 (2006).
   PubMed Web of Science ®Google Scholar
• Szeimies RM. Methyl aminolevulinate-photodynamic therapy for basal cell carcinoma. Dermatol. Clin.25(1), 89–94 (2007).
   PubMedGoogle Scholar
• Ceilley RI, Del Rosso JQ. Current modalities and new advances in the treatment of basal cell carcinoma. Int. J. Dermatol.45(5), 489–498 (2006).
   PubMed Web of Science ®Google Scholar
• Peng Q, Warloe T, Berg K et al. 5-aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges. Cancer79(12), 2282–2308 (1997).
   PubMed Web of Science ®Google Scholar
• Thissen MR, Schroeter CA, Neumann HA. Photodynamic therapy with δ-aminolaevulinic acid for nodular basal cell carcinomas using a prior debulking technique. Br. J. Dermatol.142(2), 338–339 (2000).
   PubMed Web of Science ®Google Scholar
• Wang I, Bendsoe N, Klinteberg CA et al. Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a Phase III clinical trial. Br. J. Dermatol.144(4), 832–840 (2001).
   PubMed Web of Science ®Google Scholar
• Soler AM, Warloe T, Berner A, Giercksky KE. A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated with methyl 5-aminolaevulinate-based photodynamic therapy alone and with prior curettage. Br. J. Dermatol.145(3), 467–471 (2001).
   PubMed Web of Science ®Google Scholar
• Vinciullo C, Elliott T, Francis D et al. Photodynamic therapy with topical methyl aminolaevulinate for ‘difficult-to-treat’ basal cell carcinoma. Br. J. Dermatol.152(4), 765–772 (2005).
   PubMed Web of Science ®Google Scholar
• Horn M, Wolf P, Wulf HC et al. Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment. Br. J. Dermatol.149(6), 1242–1249 (2003).
   PubMed Web of Science ®Google Scholar
• Rhodes LE, de Rie MA, Leifsdottir R et al. Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs surgery for nodular basal cell carcinoma. Arch. Dermatol.143(9), 1131–1136 (2007).
   PubMed Web of Science ®Google Scholar
• Moseley H, Allen JW, Ibbotson S et al. Ambulatory photodynamic therapy: a new concept in delivering photodynamic therapy. Br. J. Dermatol.154(4), 747–750 (2006).
   PubMed Web of Science ®Google Scholar
• de Haas ER, Sterenborg HJ, Neumann HA, Robinson DJ. Response of Bowen disease to ALA–PDT using a single and a 2-fold illumination scheme. Arch. Dermatol.143(2), 264–265 (2007).
   PubMedGoogle Scholar
• Morton C, Horn M, Leman J et al. Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or fluorouracil for treatment of squamous cell carcinoma in situ: results of a multicenter randomized trial. Arch. Dermatol.142(6), 729–735 (2006).
   PubMedGoogle Scholar
• Brookes PT, Jhawar S, Hinton CP, Murdoch S, Usman T. Bowen’s disease of the nipple – a new method of treatment. Breast14(1), 65–67 (2005).
   PubMedGoogle Scholar
• Tan B, Sinclair R, Foley P. Photodynamic therapy for subungual Bowen’s disease. Australas. J. Dermatol.45(3), 172–174 (2004).
   PubMedGoogle Scholar
• Usmani N, Stables GI, Telfer NR, Stringer MR. Subungual Bowen’s disease treated by topical aminolevulinic acid–photodynamic therapy. J. Am. Acad. Dermatol.53(5 Suppl. 1), S273–S276 (2005).
   PubMedGoogle Scholar
• Ball SB, Dawber RP. Treatment of cutaneous Bowen’s disease with particular emphasis on the problem of lower leg lesions. Australas. J. Dermatol.39(2), 63–68 (1998).
   PubMedGoogle Scholar
• Guillen C, Sanmartin O, Escudero A, Botella-Estrada R, Sevila A, Castejon P. Photodynamic therapy for in situ squamous cell carcinoma on chronic radiation dermatitis after photosensitization with 5-aminolaevulinic acid. J. Eur. Acad. Dermatol. Venereol.14(4), 298–300 (2000).
   PubMedGoogle Scholar
• Souza CS, Felicio LB, Bentley MV et al. Topical photodynamic therapy for Bowen’s disease of the digit in epidermolysis bullosa. Br. J. Dermatol.153(3), 672–674 (2005).
   PubMed Web of Science ®Google Scholar
• Stables GI, Stringer MR, Robinson DJ, Ash DV. Erythroplasia of Queyrat treated by topical aminolaevulinic acid photodynamic therapy. Br. J. Dermatol.140(3), 514–517 (1999).
   PubMed Web of Science ®Google Scholar
• Varma S, Holt PJ, Anstey AV. Erythroplasia of queyrat treated by topical aminolaevulinic acid photodynamic therapy: a cautionary tale. Br. J. Dermatol.142(4), 825–826 (2000).
   PubMedGoogle Scholar
• Wieland U, Jurk S, Weissenborn S, Krieg T, Pfister H, Ritzkowsky A. Erythroplasia of Queyrat: coinfection with cutaneous carcinogenic human papillomavirus type 8 and genital papillomaviruses in a carcinoma in situ. J. Invest. Dermatol.115(3), 396–401 (2000).
   PubMed Web of Science ®Google Scholar
• Lee MR, Ryman W. Erythroplasia of Queyrat treated with topical methyl aminolevulinate photodynamic therapy. Australas. J. Dermatol.46(3), 196–198 (2005).
   PubMedGoogle Scholar
• Paoli J, Ternesten Bratel A, Lowhagen GB, Stenquist B, Forslund O, Wennberg AM. Penile intraepithelial neoplasia: results of photodynamic therapy. Acta Derm. Venereol.86(5), 418–421 (2006).
   PubMed Web of Science ®Google Scholar
• Coors EA, von den Driesch P. Topical photodynamic therapy for patients with therapy-resistant lesions of cutaneous T-cell lymphoma. J. Am. Acad. Dermatol.50(3), 363–367 (2004).
   PubMedGoogle Scholar
• Leman JA, Dick DC, Morton CA. Topical 5-ALA photodynamic therapy for the treatment of cutaneous T-cell lymphoma. Clin. Exp. Dermatol.27(6), 516–518 (2002).
   PubMedGoogle Scholar
• Zane C, Venturini M, Sala R, Calzavara-Pinton P. Photodynamic therapy with methylaminolevulinate as a valuable treatment option for unilesional cutaneous T-cell lymphoma. Photodermatol. Photoimmunol. Photomed.22(5), 254–258 (2006).
   PubMed Web of Science ®Google Scholar
• Mori M, Campolmi P, Mavilia L, Rossi R, Cappugi P, Pimpinelli N. Topical photodynamic therapy for primary cutaneous B-cell lymphoma: a pilot study. J. Am. Acad. Dermatol.54(3), 524–526 (2006).
   PubMedGoogle Scholar
• Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N. Engl. J. Med.348(17), 1681–1691 (2003).
   PubMed Web of Science ®Google Scholar
• Dragieva G, Hafner J, Dummer R et al. Topical photodynamic therapy in the treatment of actinic keratoses and Bowen’s disease in transplant recipients. Transplantation77(1), 115–121 (2004).
   PubMedGoogle Scholar
• Dragieva G, Prinz BM, Hafner J et al. A randomized controlled clinical trial of topical photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratoses in transplant recipients. Br. J. Dermatol.151(1), 196–200 (2004).
   PubMedGoogle Scholar
• Schleier P, Hyckel P, Berndt A et al. Photodynamic therapy of virus-associated epithelial tumours of the face in organ transplant recipients. J. Cancer Res. Clin. Oncol.130(5), 279–284 (2004).
   PubMed Web of Science ®Google Scholar
• Wulf HC, Pavel S, Stender I, Bakker-Wensveen CA. Topical photodynamic therapy for prevention of new skin lesions in renal transplant recipients. Acta Derm. Venereol.86(1), 25–28 (2006).
   PubMed Web of Science ®Google Scholar
• de Graaf YG, Kennedy C, Wolterbeek R, Collen AF, Willemze R, Bouwes Bavinck JN. Photodynamic therapy does not prevent cutaneous squamous-cell carcinoma in organ-transplant recipients: results of a randomized-controlled trial. J. Invest. Dermatol.126(3), 569–574 (2006).
   PubMed Web of Science ®Google Scholar
• Perrett CM, McGregor JM, Warwick J et al. Treatment of post-transplant premalignant skin disease: a randomized intrapatient comparative study of 5-fluorouracil cream and topical photodynamic therapy. Br. J. Dermatol.156(2), 320–328 (2007).
   PubMed Web of Science ®Google Scholar
• Zheng W, Olivo M, Soo KC. The use of digitized endoscopic imaging of 5-ALA-induced PpIX fluorescence to detect and diagnose oral premalignant and malignant lesions in vivo. Int. J. Cancer110(2), 295–300 (2004).
   PubMedGoogle Scholar
• Kriegmair M, Baumgartner R, Knuchel R, Stepp H, Hofstadter F, Hofstetter A. Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence. J. Urol.155(1), 105–109 (1996).
   PubMedGoogle Scholar
• Hillemanns P, Weingandt H, Baumgartner R, Diebold J, Xiang W, Stepp H. Photodetection of cervical intraepithelial neoplasia using 5-aminolevulinic acid-induced porphyrin fluorescence. Cancer88(10), 2275–2282 (2000).
   PubMed Web of Science ®Google Scholar
• Baumgartner R, Huber RM, Schulz H et al. Inhalation of 5-aminolevulinic acid: a new technique for fluorescence detection of early stage lung cancer. J. Photochem. Photobiol. B Biol.36(2), 169–174 (1996).
   PubMed Web of Science ®Google Scholar
• Fritsch C, Becker-Wegerich PM, Menke H, Ruzicka T, Goerz G, Olbrisch RR. Successful surgery of multiple recurrent basal cell carcinomas guided by photodynamic diagnosis. Aesthetic Plast. Surg.21(6), 437–439 (1997).
   PubMed Web of Science ®Google Scholar
• Calzavara-Pinton PG, Venturini M, Sala R. Photodynamic therapy: update 2006. Part 2: clinical results. J. Eur. Acad. Dermatol. Venereol.21(4), 439–451 (2007).
   PubMedGoogle Scholar
• Ericson MB, Sandberg C, Gudmundson F, Rosen A, Larko O, Wennberg AM. Fluorescence contrast and threshold limit: implications for photodynamic diagnosis of basal cell carcinoma. J. Photochem. Photobiol. B Biol.69(2), 121–127 (2003).
   PubMed Web of Science ®Google Scholar
• Wennberg AM, Gudmundson F, Stenquist B et al.In vivo detection of basal cell carcinoma using imaging spectroscopy. Acta Derm. Venereol.79(1), 54–61 (1999).
   PubMed Web of Science ®Google Scholar
• Martin A, Tope WD, Grevelink JM et al. Lack of selectivity of protoporphyrin IX fluorescence for basal cell carcinoma after topical application of 5-aminolevulinic acid: implications for photodynamic treatment. Arch. Dermatol. Res.287(7), 665–674 (1995).
   PubMedGoogle Scholar
• Peng Q, Soler AM, Warloe T, Nesland JM, Giercksky KE. Selective distribution of porphyrins in skin thick basal cell carcinoma after topical application of methyl 5-aminolevulinate. J. Photochem. Photobiol. B Biol.62(3), 140–145 (2001).
   PubMed Web of Science ®Google Scholar
• Stender IM, Bech-Thomsen N, Poulsen T, Wulf HC. Photodynamic therapy with topical δ-aminolevulinic acid delays UV photocarcinogenesis in hairless mice. Photochem. Photobiol.66(4), 493–496 (1997).
   PubMedGoogle Scholar
• Sharfaei S, Viau G, Lui H, Bouffard D, Bissonnette R. Systemic photodynamic therapy with aminolaevulinic acid delays the appearance of ultraviolet-induced skin tumours in mice. Br. J. Dermatol.144(6), 1207–1214 (2001).
   PubMedGoogle Scholar
• Bissonnette R. Chemopreventative thoughts for photodynamic therapy. Dermatol. Clin.25(1), 95–100 (2007).
   PubMedGoogle Scholar
• Oseroff A. PDT as a cytotoxic agent and biological response modifier: implications for cancer prevention and treatment in immunosuppressed and immunocompetent patients. J. Invest. Dermatol.126(3), 542–544 (2006).
   PubMedGoogle Scholar
• Gollnick SO, Brackett CM. Enhancement of anti-tumor immunity by photodynamic therapy. Immunol. Res.46(1–3), 216–226 (20110).
   Google Scholar
• Pervaiz S, Olivo M. Art and science of photodynamic therapy. Clin. Exp. Pharmacol. Physiol.33(5–6), 551–556 (2006).
   PubMed Web of Science ®Google Scholar
• Zhou Q, Olivo M, Lye KY, Moore S, Sharma A, Chowbay B. Enhancing the therapeutic responsiveness of photodynamic therapy with the antiangiogenic agents SU5416 and SU6668 in murine nasopharyngeal carcinoma models. Cancer Chemother. Pharmacol.56(6), 569–577 (2005).
   PubMedGoogle Scholar
• Ferrario A, Von Tiehl K, Wong S, Luna M, Gomer CJ. Cyclooxygenase-2 inhibitor treatment enhances photodynamic therapy-mediated tumor response. Cancer Res.62(14), 3956–3961 (2002).
   PubMed Web of Science ®Google Scholar
• Akita Y, Kozaki K, Nakagawa A et al. Cyclooxygenase-2 is a possible target of treatment approach in conjunction with photodynamic therapy for various disorders in skin and oral cavity. Br. J. Dermatol.151(2), 472–480 (2004).
   PubMedGoogle Scholar
• Wang XL, Wang HW, Guo MX, Xu SZ. Treatment of skin cancer and pre-cancer using topical ALA-PDT – a single hospital experience. Photodiagnosis Photodyn. Ther.5(2), 127–133 (2008).
   PubMedGoogle Scholar
• Wang XL, Wang HW, Guo MX, Huang Z. Combination of immunotherapy and photodynamic therapy in the treatment of Bowenoid papulosis. Photodiagnosis Photodyn. Ther.4(2), 88–93 (2007).
   PubMedGoogle Scholar
• Cormode DP, Skajaa T, Fayad ZA, Mulder WJ. Nanotechnology in medical imaging: probe design and applications. Arterioscler. Thromb. Vasc. Biol.29(7), 992–1000 (2009).
   PubMed Web of Science ®Google Scholar
• Chatterjee DK, Fong LS, Zhang Y. Nanoparticles in photodynamic therapy: an emerging paradigm. Adv. Drug Deliv. Rev.60(15), 1627–1637 (2008).
   PubMed Web of Science ®Google Scholar
• de Leeuw J, de Vijlder HC, Bjerring P, Neumann HA. Liposomes in dermatology today. J. Eur. Acad. Dermatol. Venereol.23(5), 505–516 (2009).
   PubMed Web of Science ®Google Scholar
• Konan YN, Gurny R, Allemann E. State of the art in the delivery of photosensitizers for photodynamic therapy. J. Photochem. Photobiol. B Biol.66(2), 89–106 (2002).
   PubMed Web of Science ®Google Scholar
• Gomes AJ, Lunardi CN, Tedesco AC. Characterization of biodegradable poly(D,L-lactide-co-glycolide) nanoparticles loaded with bacteriochlorophyll-a for photodynamic therapy. Photomed. Laser Surg.25(5), 428–435 (2007).
   PubMedGoogle Scholar
• Jang WD, Nishiyama N, Zhang GD et al. Supramolecular nanocarrier of anionic dendrimer porphyrins with cationic block copolymers modified with polyethylene glycol to enhance intracellular photodynamic efficacy. Angew. Chem. Int. Ed. Engl.44(3), 419–423 (2005).
   PubMed Web of Science ®Google Scholar
• Cheng Y, Samia AC, Meyers JD, Panagopoulos I, Fei B, Burda C. Highly efficient drug delivery with gold nanoparticle vectors for In vivo photodynamic therapy of cancer. J. Am. Chem. Soc.130(32), 10643–10647 (2008).
   PubMed Web of Science ®Google Scholar
• Brevet D, Gary-Bobo M, Raehm L et al. Mannose-targeted mesoporous silica nanoparticles for photodynamic therapy. Chem. Commun. (12), 1475–1477 (2009).
   PubMedGoogle Scholar
• Tu HL, Lin YS, Lin HY et al.In vitro studies of functionalized mesoporous silica nanoparticles for photodynamic therapy. Adv. Mater.21(2), 172–177 (2009).
   Google Scholar
• Cheng SH, Lee CH, Yang CS, Tseng FG, Mou CY, Lo LW. Mesoporous silica nanoparticles functionalized with an oxygen-sensing probe for cell photodynamic therapy: potential cancer theranostics. J. Mater. Chem.19(9), 1252–1257 (2009).
   Web of Science ®Google Scholar
• Roy I, Ohulchanskyy TY, Pudavar HE et al. Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: a novel drug-carrier system for photodynamic therapy. J. Am. Chem. Soc.125(26), 7860–7865 (2003).
   PubMed Web of Science ®Google Scholar
• Bechet D, Couleaud P, Frochot C, Viriot ML, Guillemin F, Barberi-Heyob M. Nanoparticles as vehicles for delivery of photodynamic therapy agents. Trends Biotechnol.26(11), 612–621 (2008).
   PubMed Web of Science ®Google Scholar
• Kuphal S, Bosserhoff A. Recent progress in understanding the pathology of malignant melanoma. J. Pathol.219(4), 400–409 (2009).
   PubMedGoogle Scholar
• Zhao B, Yin JJ, Bilski PJ, Chignell CF, Roberts JE, He YY. Enhanced photodynamic efficacy towards melanoma cells by encapsulation of Pc4 in silica nanoparticles. Toxicol. Appl. Pharmacol.241(2), 163–172 (2009).
   PubMed Web of Science ®Google Scholar